Mealey's (May 4, 2021, 3:32 PM EDT) -- RICHMOND, Va. — The Fourth Circuit U.S. Court of Appeals on April 15 granted a joint motion to hold in abeyance the Food and Drug Administration’s appeal involving the remote prescribing of the abortion pill mifepristone during the COVID-19 pandemic after the agency on April 12 changed its position on the issue....